Orchid Pharma's newly-formed antimicrobial solutions division is targeting a turnover of up to Rs 300 crore in the next three ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, has embarked on its ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in ...

The company is involved in the manufacturing and global marketing of a diverse range of pharmaceuticals both in India and internationally. Dr. Reddy’s Labs recently acquired MenoLabs from Amyris ...

The Indian biotechnology sector is a rapidly advancing segment within the economy, often referred to as a sunrise sector due ...

Lupin Limited partners with Takeda to launch Vonoprazan tablets in India, targeting acid peptic disorders with Lupivon brand.

Aushadhi Kendra is a dedicated outlet that sells generic medicines at affordable rates. Generic medicines are 50-90% cheaper ...

India faces a rising concern as diabetes increasingly links to neurodegenerative diseases like dementia and Alzheimer’s. With ...

The pharma major informed that a meeting of its board is scheduled to be held on Friday, 20 September 2024 to mull the fund raising proposal for an amount as may be decided.

US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold ...